Progenics Pharmaceuticals, Inc. To Participate In Upcoming Conferences

TARRYTOWN, N.Y., Nov. 11, 2014 -- Progenics Pharmaceuticals, Inc., , an oncology company focused on developing innovative ways to target and treat cancer, announced today that Mark R. Baker, CEO, will participate in three upcoming investor conferences: The live webcast of the Stifel and Jefferies presentations will be available in the Media Center of the Progenics website, www.progenics.com . To ensure a timely connection, users should register at least 15 minutes prior to the scheduled start.

http://ift.tt/1zkkSCy